High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study
Table 2
Comparison of sociodemographic features, medical history findings, and metabolic syndrome components in DLE patients with and without metabolic syndrome.
Characteristics, (%)
DLE patients with MetS ()
DLE patients without MetS ()
value
Age, years, mean ± SD
Gender, (%)
Male
11 (37.9)
7 (22.6)
0.195
Female
18 (62.1)
24 (77.4)
Current smokers, (%)
17 (58.6)
17 (54.8)
0.768
Packet/year
0.715
Medical history, (%)
Diabetes mellitus and/or antidiabetic use
5 (17.2)
1 (3.2)
0.098
Hypertension and/or antihypertensive use
14 (48.3)
4 (12.9)
Hyperlipidemia/dyslipidemia and/or antihyperlipidemic use
4 (13.8)
0
Cardiovascular disease
5 (17.2)
0
Depression and/or anxiety
12 (41.4)
12 (38.7)
0.833
Body mass index, mean ± SD
0.096
Dyslipidemia, (%)
23 (79.3)
17 (54.8)
Metabolic syndrome components
Increased waist circumference ≥ 94 cm (male) or ≥ 80 cm (female)
25 (86.2)
13 (41.9)
Hypertriglyceridemia ≥ 150 mg/dL or antihyperlipidemic treatment
21 (72.4)
5 (16.1)
Reduced HDL-cholesterol < 50 mg/dL (female) or <40 mg/dL (male)
23 (79.3)
14 (45.2)
Elevated blood pressure ≥ 130/85 mmHg or antihypertensive treatment
18 (62.1)
7 (22.6)
Increased fasting blood glucose ≥ 100 mg/dL or hypoglycemic treatment
